Sangamo Therapeutics(SGMO) - 2022 Q1 - Earnings Call Presentation
Sangamo Therapeutics(SGMO)2022-05-06 14:57
Sangam Pioneering the Future of Genomic Medicines May 2022 Forward-Looking Statements This presentation contains forward-looking statements regarding our current expectations. These forward-looking statements include, without limitation, statements relating to the potential to develop, obtain regulatory approvals for and commercialize durable, safe and effective therapies to treat certain diseases and the timing, availability and costs of such therapies, the potential to use ZFP, ZFP-TF, ZFN, ZFP-Epi, CAR-T ...